Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

• Príomhchruthaitheoirí: Prof Anna Vassall, PhD (Údar), Mariana Siapka, MSc (Údar), Nicola Foster, MSc (Údar), Lucy Cunnama, MSc (Údar), Lebogang Ramma, MSc (Údar), Prof Katherine Fielding, PhD (Údar), Kerrigan McCarthy, MSc (Údar), Prof Gavin Churchyard, PhD (Údar), Prof Alison Grant, PhD (Údar), Edina Sinanovic, PhD (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2017-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. We investigated the cost-effectiveness of Xpert in...